Internal Medicine, Hematology & Oncology · Glendale, CA
NPI
1710912175
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
222 W Eulalia St Ste 100b
Glendale, CA, 91204
Phone (818) 637-7611
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.5M
496,475 services
Medicare patients, 2024
1,261
Average age 76
Drug cost, 2024
$7.6M
2,774 prescriptions
Company payments, 2025
$253
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kalust Ucar was code J1439 (injection, ferric carboxymaltose, 1 mg), 191,250 times for 116 patients. In total Kalust Ucar billed 496,475 services in 130 codes, and Medicare paid $6.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 191,250 | 116 | $0.87 | $166K |
| J0185 Injection, aprepitant, 1 mg | Office | 30,290 | 45 | $1.34 | $41K |
| J0897 Injection, denosumab, 1 mg | Office | 28,920 | 153 | $20.53 | $594K |
| Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 24,420 | 18 | $0.26 | $6,388 |
| J9267 Injection, paclitaxel, 1 mg | Office | 23,034 | 22 | $0.08 | $1,835 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,800 | 20 | $44.56 | $971K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 20,000 | 12 | $0.06 | $1,104 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 8,800 | 35 | $6.33 | $56K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 6,056 | 72 | $0.07 | $447 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 5,968 | 76 | $0.09 | $534 |
| J3245 Injection, tildrakizumab, 1 mg | Office | 3,100 | 11 | $107.89 | $334K |
| Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | Office | 2,940 | 11 | $19.97 | $59K |
| Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | Office | 2,140 | 11 | $16.41 | $35K |
| 99214 Office E&M - Established | Office | 1,569 | 800 | $102.04 | $160K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,313 | 15 | $3.57 | $4,692 |
By year: 2022 $5.1M for 414,956 services; 2023 $5.9M for 493,939 services; 2024 $6.5M for 496,475 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 38 | 15 | $2.18 | $82.93 |
Medicare prescription drug claims, 2024
In 2024, the drug Kalust Ucar prescribed most often to Medicare patients was Ondansetron Hcl, with 232 prescriptions and refills. In total Kalust Ucar wrote 2,774 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 232 | 234 | 71 | $1,463 |
| Tamoxifen Citrate Generic | 216 | 252 | 25 | $2,271 |
| Anastrozole Generic | 180 | 217 | 30 | $1,307 |
| Dexamethasone Generic | 163 | 165 | 48 | $1,733 |
| Exemestane Generic | 158 | 206 | 21 | $13K |
| Prochlorperazine Maleate Generic | 142 | 142 | 49 | $2,081 |
| Abiraterone Acetate Generic | 103 | 105 | 17 | $412K |
| Hydroxyurea Generic | 101 | 129 | 12 | $1,571 |
| Prednisone Generic | 97 | 99 | 20 | $496 |
| Tagrisso Osimertinib Mesylate | 60 | 60 | Under 11 | $974K |
| Eliquis Apixaban | 58 | 100 | 14 | $58K |
| Xtandi Enzalutamide | 56 | 56 | Under 11 | $745K |
| Letrozole Generic | 52 | 82 | Under 11 | $495 |
| Famotidine Generic | 50 | 54 | 11 | $106 |
| Procrit Epoetin Alfa | 49 | 49 | Under 11 | $136K |
Brand drugs: - claims; generic drugs: 2,113 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kalust Ucar $253 ($253 in general payments such as food, travel and fees) from 3 companies. The largest payer was Pfizer Inc. with $119.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.